Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06616259
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-17
Brief Title:
First-line Treatment of MCapOX Cetuximab Vs MFOLFOX6 Cetuximab for RASBRAF Wild-type MSS Unresectable Left-Sided MCRC a Multicenter Randomized Controlled Phase III Study
Sponsor:
Organization:
None